Therapeutic Areas



Oncology is one of the most rapidly growing areas of medicine in terms of interventional therapeutics. Boosted by innovation in imaging technology, devices, and drug development, the need for clinical trials is growing exponentially. The advances in immune-oncology, including checkpoint inhibitors and the potential to combine such drugs with loco-regional therapies, has generated a tremendous amount of enthusiasm around cancer treatments. With unmatched experience in research involving interventional or image-guided procedures, we deliver expertise in minimally invasive treatment modalities for cancer patients.

Our Successes

Over the last five years, we have successfully executed multiple full-service oncology trials and demonstrated our ability to adapt our interventional model to the oncology therapeutic area.

  • Numerous oncology trials in device and molecular diagnostics
  • Six studies enrolled >200 subjects, including interventional oncology and robotic surgery trials
  • Successful negotiation with notified body for first-in-human robot-assisted oncology study
  • Jeff Geschwind, MD, Consultant in Oncology joins the Syntactx team in 2019